-transparent.png){kind=logo}
BACKGROUND 5-Fluorouracil (5-FU) is an antimetabolite chemotherapy used for a variety of solid tumors. It has the potential to cause a wide spectrum of cardiotoxicity, ranging from asymptomatic electrocardiographic changes to cardiomyopathy and subsequent cardiac failure. Main body of the abstract: We present two descriptive cases of new-onset severe cardiomyopathy induced by 5-FU followed by a review of the literature. CONCLUSIONS Our case series emphasizes the importance of early recognition of this rare complication and prompt cessation of 5-FU, as cardiac dysfunction in this context is potentially reversible.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Cai Yuan, and
Hiral Parekh, and
Carmen Allegra, and
Thomas J George, and
Jason S Starr
January 1981,
Cancer treatment reports,
Cai Yuan, and
Hiral Parekh, and
Carmen Allegra, and
Thomas J George, and
Jason S Starr
January 2012,
Cardiology journal,
Cai Yuan, and
Hiral Parekh, and
Carmen Allegra, and
Thomas J George, and
Jason S Starr
August 2020,
Cardiovascular toxicology,
Cai Yuan, and
Hiral Parekh, and
Carmen Allegra, and
Thomas J George, and
Jason S Starr
March 1989,
Revista clinica espanola,
Cai Yuan, and
Hiral Parekh, and
Carmen Allegra, and
Thomas J George, and
Jason S Starr
February 2010,
Current oncology (Toronto, Ont.),
Cai Yuan, and
Hiral Parekh, and
Carmen Allegra, and
Thomas J George, and
Jason S Starr
June 2016,
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,
Cai Yuan, and
Hiral Parekh, and
Carmen Allegra, and
Thomas J George, and
Jason S Starr
December 2008,
Journal des maladies vasculaires,
Cai Yuan, and
Hiral Parekh, and
Carmen Allegra, and
Thomas J George, and
Jason S Starr
January 2021,
World journal of cardiology,
Cai Yuan, and
Hiral Parekh, and
Carmen Allegra, and
Thomas J George, and
Jason S Starr
January 2012,
Pakistan journal of pharmaceutical sciences,
Cai Yuan, and
Hiral Parekh, and
Carmen Allegra, and
Thomas J George, and
Jason S Starr
December 1999,
Pharmacotherapy,
